Vincent D. Enright serves as Executive at Echo Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Vincent D. Enright has executed 18 insider transactions totaling $18.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 13, 2022 involved selling 252 shares valued at $10.
Vincent D. Enright currently holds 28,200 shares of Echo Therapeutics, Inc. (ECTE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Vincent D. Enright has been a net buyer of ECTE stock. They have purchased $18.1K and sold $192 worth of shares.
Vincent D. Enright's most recent insider trade was on Jun 13, 2022, when they sold 252 shares at $0.04 per share.
Get notified when new Form 4 filings are submitted
| $0.23 |
| Discretionary |
| Dec 18, 2013 | ECTE | $0 | Award | 14,500 | $N/A | Discretionary |
| Dec 12, 2013 | LGL | $0 | Award | 1,969 | $N/A | Discretionary |
| Oct 1, 2013 | ECTE | $0 | Award | 400 | $N/A | Discretionary |
| Jul 1, 2013 | ECTE | $0 | Award | 400 | $N/A | Discretionary |
| Jul 1, 2013 | ECTE | $0 | Award | 400 | $N/A | Discretionary |
| Jun 6, 2013 | GLUXR | $123 | Sale | 252 | $0.49 | Discretionary |
| Apr 9, 2013 | ECTE | $0 | Award | 4,000 | $N/A | Discretionary |
| Jan 10, 2013 | ECTE | $0 | Award | 6,250 | $N/A | Discretionary |
| Dec 17, 2012 | LGL | $0 | Award | 1,950 | $N/A | Discretionary |
| Sep 30, 2012 | ECTE | $0 | Award | 6,250 | $N/A | Discretionary |
| Jun 30, 2012 | ECTE | $0 | Award | 6,250 | $N/A | Discretionary |
| Dec 30, 2011 | LGL | $0 | Award | 1,365 | $N/A | Discretionary |
| Sep 9, 2011 | LGL | $9.1K | Purchase | 1,000 | $9.05 | Discretionary |
| Sep 9, 2011 | LGL | $9.1K | Purchase | 1,000 | $9.05 | Discretionary |
| Mar 7, 2011 | ECTE | $0 | Award | 50,000 | $N/A | Discretionary |
| Jun 15, 2009 | ECTE | $0 | Award | 50,000 | $N/A | Discretionary |